ATE367807T1 - Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen - Google Patents

Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen

Info

Publication number
ATE367807T1
ATE367807T1 AT03776954T AT03776954T ATE367807T1 AT E367807 T1 ATE367807 T1 AT E367807T1 AT 03776954 T AT03776954 T AT 03776954T AT 03776954 T AT03776954 T AT 03776954T AT E367807 T1 ATE367807 T1 AT E367807T1
Authority
AT
Austria
Prior art keywords
anticarcinogene
depigmentant
antimutagen
medicinal product
containing medicinal
Prior art date
Application number
AT03776954T
Other languages
English (en)
Inventor
Daniel Jean
Cherif Rabhi
Original Assignee
Lmd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lmd filed Critical Lmd
Application granted granted Critical
Publication of ATE367807T1 publication Critical patent/ATE367807T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03776954T 2002-10-11 2003-10-03 Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen ATE367807T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212697A FR2845599B1 (fr) 2002-10-11 2002-10-11 Medicament comprenant une thiouree pour son utilisation en tant que depigmentant

Publications (1)

Publication Number Publication Date
ATE367807T1 true ATE367807T1 (de) 2007-08-15

Family

ID=32039668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776954T ATE367807T1 (de) 2002-10-11 2003-10-03 Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen

Country Status (12)

Country Link
US (1) US20060135618A1 (de)
EP (1) EP1553933B1 (de)
JP (1) JP2006509733A (de)
KR (1) KR20050094806A (de)
AT (1) ATE367807T1 (de)
AU (1) AU2003286213A1 (de)
CA (1) CA2501742A1 (de)
DE (1) DE60315176D1 (de)
FR (1) FR2845599B1 (de)
MX (1) MXPA05003891A (de)
NO (1) NO20052176L (de)
WO (1) WO2004032912A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881654B1 (fr) * 2005-02-07 2009-05-29 Lmd Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants
FR2890070A1 (fr) * 2005-08-31 2007-03-02 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2007039821A2 (en) * 2005-08-31 2007-04-12 Galderma Research & Development Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics
WO2008015315A1 (fr) * 2006-08-03 2008-02-07 Lmd Compositions medicinales contenant une thiouree pour le traitement du cancer en association avec des agents chimiotherapeutiques ou des rayonnements ionisants ou non ionisants
JP2012529497A (ja) * 2009-06-09 2012-11-22 シーマス リミテッド ハロゲン化脂肪族カルボン酸、そのオリゴマーおよび／またはポリマー、ならびに、表面的および内部の新生物を失活化することにおけるそれらの使用
BE1019431A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Procede de synthese d'isothiocyanates et leurs derives et utilisations de ceux-ci.
BE1019432A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Utilisation d'isothiocyanates et derives pour le traitement et/ou la prevention des lucites.
JP6130910B2 (ja) 2012-06-01 2017-05-17 ファームアグラ・ラブズ，インコーポレイテッド スルフォラファンを合成する方法
TWI508950B (zh) * 2014-08-29 2015-11-21 Univ Hungkuang 3-methyl-2-sulfanyl-2,3-dihydro-1H-imidazole-1-carboxylic acid Tertiary butyl ester and its preparation method and use
MX2019002572A (es) 2016-09-06 2019-06-06 Unilever Nv Compuestos para reducir el contenido de melanina celular.
KR102201385B1 (ko) * 2018-10-11 2021-01-11 주식회사 그라젬 피부 미백용 조성물 및 이를 이용한 미백용 화장품

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
ATE367157T1 (de) * 2000-02-29 2007-08-15 Mediquest Therapeutics Inc Melanocyt-tyrosinase hemmer als topische hautdepigmentierende mittel
FR2820036B1 (fr) * 2001-01-26 2005-12-09 L M D Utilisation d'un isothiocyanate, d'un thiocyanate ou de leur melange en tant que depigmentant

Also Published As

Publication number Publication date
FR2845599B1 (fr) 2005-01-07
JP2006509733A (ja) 2006-03-23
CA2501742A1 (fr) 2004-04-22
US20060135618A1 (en) 2006-06-22
DE60315176D1 (de) 2007-09-06
WO2004032912A1 (fr) 2004-04-22
AU2003286213A1 (en) 2004-05-04
MXPA05003891A (es) 2005-08-03
NO20052176L (no) 2005-05-03
KR20050094806A (ko) 2005-09-28
FR2845599A1 (fr) 2004-04-16
EP1553933B1 (de) 2007-07-25
EP1553933A1 (de) 2005-07-20

Similar Documents

Publication Publication Date Title
NO20052176L (no) Legemiddel som omfatter et tiourea for anvendelse som et depigmenteringsmiddel, eller antimutagent og antikarsinogent middel
BRPI0412219B8 (pt) compostos ômega-carboxi aril difenil uréia fluoro substituídos e composições farmacêuticas compreendendo os referidos compostos
HUP0400206A2 (hu) Metalloproteináz inhibitor hatású imidazolidin-dion-származékok, ezek alkalmazása gyógyszerkészítmények előállítására és ezeket tartalmazó gyógyszerkészítmények
AU2804400A (en) Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
ATE469161T1 (de) Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung
ATE526319T1 (de) Aktivator für den peroxisome proliferator- responsiven rezeptor delta
DE60330407D1 (de) Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
NO20050294L (no) Nye forbindelser nyttige i behandlingen av fedme, type II diabetes og CNS forstyrrelser
HUP0301749A2 (hu) Acilfenil-karbamid-származékok, eljárás az elżállításukra és gyógyszerkénti alkalmazásuk
BRPI0407283A (pt) Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade
BR0013667A (pt) Derivados de glucopiranosiloxipirazol, composições medicinais contendo os mesmos derivados e seus intermediários na produção dos mesmos
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
ATE548032T1 (de) Verwendung von chlorguanabenzderivaten zur behandlung von mit polyglutaminexpansion assoziierten erkrankungen
TR200103349T2 (tr) Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri.
NO20050903L (no) Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser
YU90203A (sh) Upotreba adenozina i analoga za izradu lekova za tretman sindroma rezistentnosti na insulin i dijabetesa
BR0114424A (pt) Derivados de 5-amidino-2-hidróxi benzeno sulfonamida, composições farmacêuticas contendo os mesmos e intermediários para a sua preparação
ATE487685T1 (de) (-)-stereoisomer von 2,6-di-sec-butylphenol und analoga davon
NO20055754L (no) Kolkisosidanaloger
MA27649A1 (fr) Derives d&#39;acylphenyluree substitues par carbonylamino, methode de production et d&#39;utilisation de ceux-ci.
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
SE8300855L (sv) Nya piperazin- och homopiperazinderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande dem
HUP0303512A2 (hu) Biuretánszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ATE118346T1 (de) Verwendung von bis(4-hydroxyphenylthio)methan- derivaten zur behandlung von diabetes mellitus.
KR950032191A (ko) 사이클로헥산 유도체, 이의 제조방법 및 질병을 치료하기 위한 화합물의 용도

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties